Steven Assalita
Cardiovascular Disease · Houston, TXNPI 1184967937
Payments from drug & device makers
Across 84 payments — averaging $42.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Amgen$340
- Novartis$196
- Irhythm Technologies, Inc.$171
- E.r. Squibb & Sons, L.L.C.$145
- Medtronic$138
- plus $558 from 14 others
Across 1 payment — averaging $149.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$149
What the payments were for
- Food & beverage$3,34094%
- Education$1956%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 16 | $1,987 |
| Amgen | 17 | $340 |
| Novartis | 7 | $196 |
| Irhythm Technologies, Inc. | 12 | $171 |
| E.r. Squibb & Sons, L.L.C. | 3 | $145 |
| Medtronic | 1 | $138 |
| AstraZeneca | 6 | $89 |
| Boston Scientific | 4 | $83 |
| Arineta, Inc | 1 | $74 |
| Teleflex LLC | 3 | $59 |
| Lantheus Medical Imaging, Inc. | 2 | $46 |
| Johnson & Johnson | 3 | $41 |
| Cvrx, Inc. | 1 | $36 |
| Boehringer Ingelheim | 2 | $26 |
| Heartflow, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $21 |
| Bardy Diagnostics, Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,535 in reported general payments places this provider in the 45th percentile of 1,515 cardiovascular disease providers in Texas.
Other cardiovascular disease in Houston
- Christie BallantyneHouston$4.6M
- Syed NaqviHouston$3.6M
- James FeldmanHouston$3.1M
- Aditya SamalHouston$2.6M
- Pranav LoyalkaHouston$2.4M
- Anwar AhmadHouston$1.4M
- Reynolds DelgadoHouston$1.1M
- Richard SmallingHouston$908K
- Amin KarimHouston$853K
- Stephen LittleHouston$806K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.